Axa »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Axa

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Axa from 13F filings

Historical chart of Axa investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Axa consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Axa

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.1M 6.1M 1.17
2023-09-30 $7.1M 6.4M 1.12

More positions owned by Axa

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Broadcom (AVGO)
Stellantis SHS (STLA)
Intuitive Surgical Com New (ISRG)
UnitedHealth (UNH)
Meta Platforms Cl A (META)
Cadence Design Systems (CDNS)
Thermo Fisher Scientific (TMO)
Qualcomm (QCOM)

View all positions for Axa

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Wolverine Asset Management
Calamos Advisors
BlackRock
Braidwell
Lazard Asset Management
Davidson Kempner Capital Management
Readystate Asset Management
Citadel Advisors
Steelhead Partners
Bank of America Corporation
D. E. Shaw & Co
Tenor Capital Management
Bank Of Montreal
FMR
Nuveen Asset Management

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1